Patents by Inventor Sharon Mates

Sharon Mates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORGANIC COMPOUNDS
    Publication number: 20100087450
    Abstract: The present invention relates to a new use of phosphodiesterase 1 (PDE1) inhibitors for the treatment and/or prophylaxis of narcolepsy.
    Type: Application
    Filed: November 13, 2007
    Publication date: April 8, 2010
    Applicant: Intra-Cellular Therapies, Inc.
    Inventors: Sharon Mates, Allen A. Fienberg
  • Organic Compounds
    Publication number: 20080194592
    Abstract: The invention provides a new method of treating diseases or conditions characterized by reduced dopamine D1 receptor signaling activity, such as Parkinson's disease, depression, and cognitive impairment of schizophrenia, comprising administering an effective amount of a 1,3,5,-substituted, 6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-7-one to a patient in need thereof.
    Type: Application
    Filed: August 23, 2006
    Publication date: August 14, 2008
    Applicant: Intra-Cellular Therapies, Inc.
    Inventors: Sharon Mates, Lawrence P. Wennogle
  • Vaccines against group C Neisseria meningitidis
    Patent number: 5425946
    Abstract: An immunogenic conjugate comprising a modified group C meningococcal polysaccharide (GCMP) coupled to a carrier molecule. The GCMP is modified by O-deacetylation to a varying extent. This modified GCMP conjugate stimulates a strong immunogenic response. The antiserum, produced by immunization with this conjugate, is cross-reactive with the native polysaccharide. In addition, these antisera elicit a class of antibodies that have patent bactericidal activity.
    Type: Grant
    Filed: August 31, 1992
    Date of Patent: June 20, 1995
    Assignee: North American Vaccine, Inc.
    Inventors: Joseph Y. Tai, Lucjan J. J. Hronowski, Sharon Mates